Study of curative effect and safety of low dose of urokinase combined with low molecular heparin calcim
10.3760/cma.j.issn.1673-4904.2011.34.002
- VernacularTitle:小剂量尿激酶联合低分子肝素钙在心肺复苏中的疗效和安全性研究
- Author:
Yi XIE
;
Guicai LI
;
Jianhong GUO
;
Hanbo CHEN
;
Shuxin ZHENG
;
Bin HUANG
;
Ruiqi ZHENG
- Publication Type:Journal Article
- Keywords:
Cardiopulmonary resuscitation;
Urinary plasminogen activator;
Treatment outcome;
Low molecular heparin calcium;
Safety
- From:
Chinese Journal of Postgraduates of Medicine
2011;34(34):4-7
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo study the curative effect and safety of low dose of urokinase (UK) combined with low molecular heparin calcium.MethodsSixty-four cases of sudden cardiac arrest patients were divided into treatment group and control group by random digits table with 32 cases each.Two groups were given cardiopulmonary resuscitation according to the 2005 international guide for cardiopulmonary resuscitation and emergency cardiovascular care.Early in the recovery,the patients in treatment group were pumped in vein with low dose of UK(200 000 U) and injected subcutaneous with low molecular heparin calcium (4100 U ) in 30 minutes.The rate of return of spontaneous circulation (ROSC),survival rate longer than 24 hours and 30 days in two groups and patients dying of bleeding or bleeding conditions in treatment group were observed.ResultsThere were 11 cases (34.4％) of ROSC in control group,and compared with 20 cases (62.5％) in treatment group,there was significant difference (P＜0.05).There were 5 cases (15.6％) of survival longer than 24 hours in control group,and compared with 13 cases(40.6％) in treatment group,there was significant difference (P ＜ 0.05 ).There were 2 cases (6.2％) of survival 30 days in control group,and compared with 8 cases (25.0％) in treatment group,there was significant difference (P＜ 0.01 ).Nobody had subcutaneous bleeding or other organ hemorrhage in control group.But there was I patient who had subcutaneous limited ecchymosis in the injection site in treatment group.The difference of fibrinogen before and after treatment in treatment group was statistically significant(P ＜ 0.01 ),but there was no significant difference in prothrombin time and platelet count before and after treatment in treatment group (P ＞ 0.05).ConclusionsIt is safe and effective in cardiopulmonary resuscitation with low dose of UK combined with low molecular heparin calcium.
